Keith Parent, CEO of Court Square Group, discusses the intersection of science and business in drug development with Dr. Joseph Geraci, Founder, Chief Scientific and Technical Officer of NetraMark. Dr. Geraci, with a background in mathematics and AI, focuses on understanding patient populations and improving clinical trials. He explains how NetraMark's AI technology can analyze small, complex data sets to identify treatment and placebo responder subpopulations and improve drug efficacy. Dr. Geraci emphasizes the potential of adaptive trials and the importance of personalized medicine. He predicts the future of AI in clinical trials will involve modular AI systems integrating pattern-finding and language interfaces to enhance drug development and patient care.

Driving the Business of Science is the podcast for clinical operations, IT, and business managers in the pharma, biotech, and medical device world.

Bringing new products to market takes more than just great science. From R&D and clinical to regulatory and approval life science leaders require fit-for-purpose technology, processes, and partners at step.

In the Driving the Business of Science podcast leaders from across the life science industry share real-world experiences and practical insights that will impact your business.

Join host Keith Parent, serial life science CEO, as business leaders share experiences and insights on emerging challenges in the life science market.